MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 10177-10184

  Liu, Zhiguo ^a   Liu, Yuguang ^a   Li, Lianling ^a   Xu, Zhenkuan ^a   Bi, Baibin ^a   Wang, Yunyan ^a   Li, Jian Yi ^b  

^a SHANDONG UNIVERSITY   (China)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

Glioblastoma; Microvasculature; MiR 7 5p; Proliferation; RAF1

Indexed keywords

MICRORNA; MIRN7 MICRORNA, HUMAN; RAF PROTEIN; TRANSCRIPTOME;

ADULT; AGED; BRAIN TUMOR; CELL PROLIFERATION; DNA MICROARRAY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; HUMAN; MALE; METABOLISM; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; VASCULARIZATION;

ADULT; AGED; BRAIN NEOPLASMS; CELL PROLIFERATION; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; MALE; MICRORNAS; MICROVESSELS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-RAF; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84922394836     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2318-x     Document Type: Article

References (32)

1. Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–5.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.
3. Pasquinelli AE, Hunter S, Bracht J. MicroRNAs: a developing story. Curr Opin Genet Dev. 2005;15(2):200–5.
4. Ahmed FE. Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn. 2007;7(5):569–603.
5. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122 (1):6–7.
6. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res. 2005;65(9):3509–12.
7. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10(10):704–14.
8. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60(3):166–93.
9. Kraus JA, Lamszus K, Glesmann N, Beck M, Wolter M, Sabel M, et al. Molecular genetic alterations in glioblastomas with oligoden-droglial component. Acta Neuropathol. 2001;101(4):311–20.
10. Fuller GN, The WHO. Classification of tumours of the central nervous system, 4th edition. Arch Pathol Lab Med. 2008;132(6):906.
11. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061–8.
12. Zhang C, Li C, Li J, Han J, Shang D, Zhang Y, et al. Identification of miRNA-mediated core gene module for glioma patient prediction by integrating high-throughput miRNA, mRNA expression and pathway structure. PLoS One. 2014;9(5):e96908.
13. Li JY, Boado RJ, Pardridge WM. Blood–brain barrier genomics. J Cereb Blood Flow Metab. 2001;21(1):61–8.
14. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, Purow B. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008; 68 (10): 3566–3572
15. Kyriakis JM. The integration of signaling by multiprotein complexes containing Raf kinases. Biochim Biophys Acta. 2007;1773(8): 1238–47.
16. Leicht DT, Balan V, Kaplun A, Singh-Gupta V, Kaplun L, Dobson M, et al. Raf kinases: function, regulation and role in human cancer. Biochim Biophys Acta. 2007;1773(8):1196–212.
17. McPhillips F, Mullen P, MacLeod KG, Sewell JM, Monia BP, Cameron DA, et al. Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells. Carcinogenesis. 2006;27(4):729–39.
18. Zebisch A, Troppmair J. Back to the roots: the remarkable RAF oncogene story. Cell Mol Life Sci. 2006;63(11):1314–30.
19. Pal A, Ahmad A, Khan S, Sakabe I, Zhang C, Kasid UN, et al. Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer. Int J Oncol. 2005;26(4):1087–91.
20. Fushimi K, Nakashima S, You F, Takigawa M, Shimizu K. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation. J Cell Biochem. 2007;100(3):783–93.
21. von Kriegsheim A, Pitt A, Grindlay GJ, Kolch W, Dhillon AS. Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5. Nat Cell Biol. 2006;8(9):1011–6.
22. von B, V, Dubben S, Engelhardt G, Hebel S, Plumakers B, Heine H, Rink L, Haase H. Zinc-dependent suppression of TNF-alpha production is mediated by protein kinase A-induced inhibition of Raf-1, I kappa B kinase beta, and NF-kappa B. J Immunol 2007; 179(6): 4180–4186
23. Li Y, Levesque LO, Anand-Srivastava MB. Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR. Am J Physiol Heart Circ Physiol. 2010;299(6):H1959–67.
24. Maretzky T, Evers A, Zhou W, Swendeman SL, Wong PM, Rafii S, et al. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17. Nat Commun. 2011;2:229.
25. Kyriakakis E, Cavallari M, Pfaff D, Fabbro D, Mestan J, Philippova M, et al. IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation. J Leukoc Biol. 2011;90(5):929–39.
26. Guang-Wu H, Sunagawa M, Jie-En L, Shimada S, Gang Z, Tokeshi Y, et al. The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope. 2000;110(12):2066–9.
27. Goel HL, Mercurio AM. VEGF targets the tumour cell. Nat Rev Cancer. 2013;13(12):871–82.
28. Chen Y, Rabson AB, Gorski DH. MEOX2 regulates nuclear factor-kappaB activity in vascular endothelial cells through interactions with p65 and IkappaBbeta. Cardiovasc Res. 2010;87(4):723–31.
29. Chiplunkar AR, Curtis BC, Eades GL, Kane MS, Fox SJ, Haar JL, et al. The Kruppel-like factor 2 and Kruppel-like factor 4 genes interact to maintain endothelial integrity in mouse embryonic vasculogenesis. BMC Dev Biol. 2013;13:40.
30. Zhang Y, Chen N, Zhang J, Tong Y. Hsa-let-7 g miRNA targets caspase-3 and inhibits the apoptosis induced by ox-LDL in endothe-lial cells. Int J Mol Sci. 2013;14(11):22708–20.
31. Lee JW, Soung YH, Kim SY, Nam SW, Park WS, Lee JY, et al. Absence of JAK2 V617F mutation in gastric cancers. Acta Oncol. 2006;45(2):222–3.
32. Orom UA, Kauppinen S, Lund AH. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene. 2006;372: 137–41.